BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cognito Therapeutics Inc.

Headquarters: Newton Centre, MA, United States of America
Year Founded: 2016
Status: Private

BioCentury | Feb 13, 2025
Management Tracks

Lee joins Lycia as CMO

Plus: Firth joins Panacea, Lakewood appoints Manion chair and updates from Ai Proteins, Cognito and Kala
BioCentury | Aug 27, 2024
Management Tracks

Patel joins Sana as EVP, CSO

Plus: Ian Clements named CFO of Marea, new role at BII for Soni and more
BioCentury | Oct 31, 2023
Management Tracks

Vir names Jennifer Towne CSO

Plus: Genentech’s Amit Mehta joins Dren Bio, and updates from Rapport, Mozart and Cognito
BioCentury | Oct 18, 2023
Management Tracks

eTheRNA names Sagaert CEO, Dekkers as chairman

Plus: Cyrus Harmon becomes CEO at Vilya, and updates from Epic Bio, Exscientia, Pliant, Cognito, Pattern
BioCentury | Mar 9, 2022
Finance

March 8 Quick Takes: Blackstone backs DNAnexus with $200M

Plus Sherlock raises $80M and updates from WuXi AppTec, Mustang, UroGen and more
BioCentury | May 8, 2021
Management Tracks

Turnstone announces Burgess’ move to executive chairman alongside pair of promotions; plus Fulgent, Centene FDS, Akouos and more

Turnstone Biologics Inc. President of R&D Mike Burgess will become executive chairman of R&D. The cancer immunotherapy company also promoted José Otero to CTO from SVP of
BioCentury | Dec 9, 2016
Company News

MIT, Cognito deal

Items per page:
1 - 7 of 7
Help Center
Username
Request Training
Submit Data Correction
Ask a Question